SCHEMBL2294455

SCHEMBL2294455

CC(C)(C)[C@@](CC(=O)O)(Nc1ccccc1N)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.47
HIF1A Q16665 1/20 0.47
HDAC1 Q13547 12/20 0.41
HDAC3 O15379 9/20 0.41
HDAC2 Q92769 7/20 0.41
MAPK1 P28482 1/20 0.41
MAPK13 O15264 1/20 0.40
MAPK12 P53778 1/20 0.40
MAPK11 Q15759 1/20 0.40
MAPK14 Q16539 1/20 0.40
NCOR2 Q9Y618 4/20 0.39
HDAC4 P56524 3/20 0.39
HDAC7 Q8WUI4 3/20 0.39
HDAC10 Q969S8 3/20 0.39
HDAC11 Q96DB2 3/20 0.39
HDAC8 Q9BY41 3/20 0.39
HDAC6 Q9UBN7 3/20 0.39
HDAC9 Q9UKV0 3/20 0.39
HDAC5 Q9UQL6 3/20 0.39
MAPT P10636 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13727656 0.81 HDAC1 (0.45) CYP2C19HIF1AHDAC1HDAC3HDAC2
SCHEMBL2294500 0.80 KMT2A (0.47) CYP2C19HIF1AMAPK1MAPTKMT2A
SCHEMBL5206145 0.73 HDAC1 (0.41) CYP2C19HDAC1HDAC3HDAC2MAPK1
SCHEMBL11659911 0.73 HDAC1 (0.49) CYP2C19HDAC1HDAC3HDAC2MAPK1
SCHEMBL28400732 0.71 ALDH1A1 (0.50) CYP2C19HIF1AMAPTKDM4EALDH1A1
SCHEMBL19775165 0.68 MAPT (0.43) CYP2C19HDAC1HDAC3HDAC2MAPK1
SCHEMBL29666932 0.67 MAPT (0.46) CYP2C19HDAC1HDAC3HDAC2MAPK1
SCHEMBL1269273 0.67 MAPT (0.46) CYP2C19HDAC1HDAC3HDAC2MAPK1
SCHEMBL1573830 0.67 CYP2C19 (0.60) CYP2C19HIF1AHDAC1HDAC3HDAC2
SCHEMBL9806434 0.67 NPSR1 (0.44) CYP2C19HDAC1HDAC3HDAC2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003806-B2 Integrin antagonists useful as anticancer agents OSI Pharmaceuticals, LLC (US) 2011-08-23 US disclosed